Study Of GSK1358820 In Patients With Post-Stroke Upper Limb Spasticity
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This is a study to confirm the superior efficacy of a single treatment of GSK1358820 over
placebo in patients with post-stroke upper limb spasticity of both the wrist and finger
flexors using the Modified Ashworth Scale (MAS) wrist score.
Phase:
Phase 3
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A incobotulinumtoxinA onabotulinumtoxinA